{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:26:07Z","timestamp":1792733167965,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1124\/jpet.112.199430","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T20:30:31Z","timestamp":1351024231000},"page":"196-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation"],"prefix":"10.1016","volume":"344","author":[{"given":"Robert W.","family":"Busby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilmin P.","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hannig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Solinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny V.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.199430_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2007.06.067","article-title":"Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome","volume":"133","author":"Andresen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.199430_bib2","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1074\/jbc.M809338200","article-title":"Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase","volume":"284","author":"Zahedi Avval","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.199430_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jps.3030360408","article-title":"The carboxypeptidase activity of pancreatin U.S.P","volume":"36","author":"Bauer","year":"1947","journal-title":"J Am Pharm Assoc Am Pharm Assoc"},{"key":"10.1124\/jpet.112.199430_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/iai.47.1.242-246.1985","article-title":"Escherichia coli heat-stable enterotoxin","volume":"47","author":"Brandwein","year":"1985","journal-title":"Infect Immun"},{"key":"10.1124\/jpet.112.199430_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.lfs.2010.03.015","article-title":"Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract","volume":"86","author":"Bryant","year":"2010","journal-title":"Life Sci"},{"key":"10.1124\/jpet.112.199430_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2010.09.019","article-title":"Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit","volume":"649","author":"Busby","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.199430_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2012.254","article-title":"Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety","author":"Chey","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.112.199430_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1073\/pnas.89.3.947","article-title":"Guanylin: an endogenous activator of intestinal guanylate cyclase","volume":"89","author":"Currie","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199430_bib12","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/jn\/130.11.2739","article-title":"Rat jejunum controls luminal thiol-disulfide redox","volume":"130","author":"Dahm","year":"2000","journal-title":"J Nutr"},{"key":"10.1124\/jpet.112.199430_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.physiol.66.032102.144149","article-title":"Molecular and integrative physiology of intestinal peptide transport","volume":"66","author":"Daniel","year":"2004","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/jpet.112.199430_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2982.2009.01385.x","article-title":"Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain","volume":"22","author":"Eutamene","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1124\/jpet.112.199430_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/bbrc.1996.0255","article-title":"Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma","volume":"219","author":"Fan","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.112.199430_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/152308604771978354","article-title":"Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system","volume":"6","author":"Fernandes","year":"2004","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.112.199430_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0160-5402(90)90050-U","article-title":"Cecectomized rat. A model of experimental secretory diarrhea in conscious animals","volume":"24","author":"Fondacaro","year":"1990","journal-title":"J Pharmacol Methods"},{"key":"10.1124\/jpet.112.199430_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pharmthera.2004.08.007","article-title":"Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics","volume":"104","author":"Forte","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.112.199430_bib19","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.90.22.10464","article-title":"Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase","volume":"90","author":"Hamra","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199430_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/endo.137.1.8536621","article-title":"Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases","volume":"137","author":"Hamra","year":"1996","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.199430_bib21","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1073\/pnas.94.6.2705","article-title":"Regulation of intestinal uroguanylin\/guanylin receptor-mediated responses by mucosal acidity","volume":"94","author":"Hamra","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.199430_bib22","series-title":"Physiology of the Gastrointestinal Tract","author":"Johnson","year":"1994"},{"key":"10.1124\/jpet.112.199430_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2010.08.041","article-title":"Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation","volume":"139","author":"Johnston","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.199430_bib43","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI106938","article-title":"Peptide hydrolases in the brush border and soluble fractions of small intestinal mucosa of rat and man","volume":"51","author":"Kim","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.112.199430_bib44","first-page":"407","article-title":"Distribution of heat-stable enterotoxin\/guanylin receptors in the intestinal tract of man and other mammals","volume":"184","author":"Krause","year":"1994","journal-title":"J Anat"},{"key":"10.1124\/jpet.112.199430_bib25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2009.12.050","article-title":"Efficacy of linaclotide for patients with chronic constipation","volume":"138","author":"Lembo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.199430_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJMoa1010863","article-title":"Two randomized trials of linaclotide for chronic constipation","volume":"365","author":"Lembo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.112.199430_bib27","article-title":"Signal transduction pathways via guanylin and uroguanylin in stomach and intestine","volume":"273","author":"London","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.112.199430_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.2006.101675","article-title":"Functional GI disorders: from animal models to drug development","volume":"57","author":"Mayer","year":"2008","journal-title":"Gut"},{"key":"10.1124\/jpet.112.199430_bib30","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1210\/endo.141.9.7644","article-title":"Expression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine","volume":"141","author":"Qian","year":"2000","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.199430_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2012.255","article-title":"A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation","author":"Rao","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.112.199430_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/egh.11.30","article-title":"Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation","volume":"5","author":"Roque","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1124\/jpet.112.199430_bib33","first-page":"795","article-title":"Human aminopeptidases: a review of the literature","volume":"26","author":"Sanderink","year":"1988","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1124\/jpet.112.199430_bib34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0092-8674(90)90497-3","article-title":"Guanylyl cyclase is a heat-stable enterotoxin receptor","volume":"63","author":"Schulz","year":"1990","journal-title":"Cell"},{"key":"10.1124\/jpet.112.199430_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1079\/PNS19850011","article-title":"Protein digestion and amino acid and peptide absorption","volume":"44","author":"Silk","year":"1985","journal-title":"Proc Nutr Soc"},{"key":"10.1124\/jpet.112.199430_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.gastro.2003.11.005","article-title":"Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor","volume":"126","author":"Thiagarajah","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.199430_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0003-2697(85)90623-2","article-title":"125I-4Tyr and -18 Escherichia coli heat-stable enterotoxin species purified by high-performance liquid chromatography","volume":"148","author":"Thompson","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.112.199430_bib37","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1345\/aph.1Q428","article-title":"Linaclotide: a novel approach to the treatment of irritable bowel syndrome","volume":"45","author":"Wensel","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.112.199430_bib38","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0006-291X(92)91699-Q","article-title":"Rat guanylin cDNA: characterization of the precursor of an endogenous activator of intestinal guanylate cyclase","volume":"185","author":"Wiegand","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.112.199430_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0169-409X(97)00040-9","article-title":"The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans","volume":"27","author":"Wilkinson","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.112.199430_bib40","first-page":"61","article-title":"Enzymatic barriers for GI peptide and protein delivery","volume":"11","author":"Woodley","year":"1994","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1124\/jpet.112.199430_bib41","first-page":"2257","article-title":"Effects of peptides, with emphasis on feeding, pain, and behavior: a 5-year (1999\u20132003) review of publications in Peptides","volume":"25","author":"Yu","year":"2004","journal-title":"Peptides"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524184789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524184789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.199430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:17:36Z","timestamp":1739967456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524184789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0022356524184789"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.199430","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719105613.793516780","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.199430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}